These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 18908365)

  • 1. The role of pressor amines in the etiology of experimental and essential hypertension.
    HELMER OM; PEIRCE JD; SHIPLEY RE
    Proc Am Fed Clin Res; 1947; 3(1 Vol):22. PubMed ID: 18908365
    [No Abstract]   [Full Text] [Related]  

  • 2. Fundamental basis of the specificity of pressor and depressor amines in their vascular effects. II. Effects of dibenamine on the hypertensive action of pressor amines.
    HUIDOBRO F; CROXATTO R; MANOSALVA W
    Acta Physiol Lat Am; 1951 Jul; 1(3):187-99. PubMed ID: 14943549
    [No Abstract]   [Full Text] [Related]  

  • 3. Fundamental basis of the specificity of pressor and depressor amines in their vascular effects. I. Blockade of the hypertensive action of vasopressor amines by the effect of the same substances.
    HUIDOBRO F; CROXATTO R; ALLENDE J; DEL RIO J
    Acta Physiol Lat Am; 1951 Feb; 1(2):91-109. PubMed ID: 14943542
    [No Abstract]   [Full Text] [Related]  

  • 4. Pressor substances in arterial hypertension; activity and amine content of crude extracts of blood.
    STOCK CC; SCHROEDER HA
    Am J Physiol; 1950 Feb; 160(2):409-20. PubMed ID: 15406337
    [No Abstract]   [Full Text] [Related]  

  • 5. Certain pressor-depressor tests in essential hypertension; a comparison and comment.
    POSTELLI T; PALMER RS
    Am Pract Dig Treat; 1949 Sep; 4(1):9-14. PubMed ID: 18147818
    [No Abstract]   [Full Text] [Related]  

  • 6. Fundamental basis of the specificity of pressor and depressor amines in their vascular effects. III. The specific hypotensive action of some pressor amines.
    HUIDOBRO F; CROXATTO R
    Acta Physiol Lat Am; 1951 Dec; 1(4):277-90. PubMed ID: 14943556
    [No Abstract]   [Full Text] [Related]  

  • 7. Pathogenesis of essential hypertension.
    SMIRK FH
    Br Med J; 1949 May; 1(4609):791-9. PubMed ID: 18120848
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of methylphenidate on cardiovascular actions of pressor amines.
    POVALSKI HJ; GOLDSMITH ED
    Proc Soc Exp Biol Med; 1959; 101():717-21. PubMed ID: 14434542
    [No Abstract]   [Full Text] [Related]  

  • 9. The pathogenic patterns of essential hypertension.
    RAAB W
    Exp Med Surg; 1948 Nov; 6(4):464-86. PubMed ID: 18104774
    [No Abstract]   [Full Text] [Related]  

  • 10. Psychosomatic factors in essential hypertension.
    LIPKIN M
    Med Clin North Am; 1949 May; 33(3):703-12. PubMed ID: 18120139
    [No Abstract]   [Full Text] [Related]  

  • 11. Fall of blood pressure after a noradrenaline infusion and its treatment by pressor agents.
    BURN JH; RAND MJ
    Br Med J; 1959 Feb; 1(5119):394-7. PubMed ID: 13618647
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical and experimental observations on the lability and range of blood pressure in essential hypertension, with special reference to physiologic mechanisms and significance of various pressor and depressor tests.
    REISER MF; FERRIS EB
    J Clin Invest; 1947 Nov; 26(6):1194. PubMed ID: 20340969
    [No Abstract]   [Full Text] [Related]  

  • 13. Pressor--depressor counterregulation in experimental hypertension induced by various methods.
    KOVER A; BEREGSZASZY G; MOLNAR G; WENT I
    Acta Physiol Acad Sci Hung; 1960; 18():37-45. PubMed ID: 13753685
    [No Abstract]   [Full Text] [Related]  

  • 14. The mechanism of the fall in arterial pressure produced by high spinal anesthesia in patients with essential hypertension.
    LEVIN WC; ROSS GT
    Fed Proc; 1946; 5(1 Pt 2):62. PubMed ID: 21066327
    [No Abstract]   [Full Text] [Related]  

  • 15. Renin in essential hypertension.
    TAQUINI AC; FASCIOLO JC
    Am Heart J; 1946 Sep; 32():357-63. PubMed ID: 20996763
    [No Abstract]   [Full Text] [Related]  

  • 16. Postpartum hypertension after use of vasoconstrictor and oxytocic drugs. Etiology, incidence, complications, and treatment.
    CASADY GN; MOORE DC; BRIDENBAUGH LD
    J Am Med Assoc; 1960 Mar; 172():1011-5. PubMed ID: 13808093
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pressor effects of vitamin A; experimental investigations].
    CANNAVA A; CAVALLERI L
    Arch Maragliano Patol Clin; 1950; 5(6):1181-8. PubMed ID: 14811669
    [No Abstract]   [Full Text] [Related]  

  • 18. The interaction of sympathomimetic pressor amines; inversion of the vonedrine pressor action by paredrine.
    AHLQUIST RP
    J Am Pharm Assoc Am Pharm Assoc; 1946 Nov; 35(11):348-50. PubMed ID: 20274504
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiovascular evaluation of a pressor amine (tetrahydrozoline) showing hypotensive properties in man.
    FINNERTY FA; BUCHHOLZ JH; GUILLAUDEU RL
    Proc Soc Exp Biol Med; 1957 Feb; 94(2):376-9. PubMed ID: 13408265
    [No Abstract]   [Full Text] [Related]  

  • 20. Observations on the sustained pressor principle in different animal species.
    SHIPLEY RE; HELMER OM
    Am J Physiol; 1948 May; 153(2):341-7. PubMed ID: 18872648
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.